In-vitro Diagnostic Services Market Size By Service Type {Software (Standalone Software, Software Update), Testing Services (Infectious Testing, Diabetes Testing, Molecular Testing, Tissue Testing)}, By End-user (Hospitals, Point-Of-Care Testing, Laboratories, Academic Institutes), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2018 – 2024

Published Date: Sep 2018  |  Report ID: GMI2889  |  Authors: Sumant Ugalmugle

Report Format: PDF   |   Pages: 185   |   Base Year: 2017




Summary Table of Contents Industry Coverage Methodology

Industry Trends

In-vitro Diagnostic Services market size was valued at USD 44.0 billion in 2017 and is expected to witness 5.4% CAGR from 2018 to 2024.
 

In-vitro Diagnostic Services Market

Get more details on this report - Request Free Sample PDF
 

Rising number of cancer cases in Asian as well as western countries should drive in-vitro diagnostic services industry growth in upcoming years. According to Livemint in 2016, India had over 3.9 million cases of cancer that will accelerate the demand for in-vitro diagnostic services. Moreover, growing elderly population suffering from chronic diseases such as diabetes and cardiovascular disorders will influence the industry growth. In the U.S., there are around 78 million people in the age group of 65 years and above. Majority of elderly people suffer from at least one chronic disease or infection that should upsurge the demand for in-vitro diagnostic services in near future.
 

Increasing rate of detection of genetic and infectious diseases in developed economies will escalate IVD services industry growth. Over 133 million Americans are detected with at least one chronic disease that will increase the demand for in-vitro diagnostic services surging industry growth. American organizations such as National Association of Chronic Diseases implements certain initiatives that will raise awareness of disease detection among the population should positively influence in-vitro diagnostic services industry growth. However, high costs associated with diagnostic services will restrain industry growth.
 

In-vitro Diagnostic Services Market Report Coverage
Report Coverage Details
Base Year: 2017 Market Size in 2017: 44 Billion (USD)
Historical Data for: 2013 to 2017 Forecast Period: 2018 to 2024
Forecast Period 2018 to 2024 CAGR: 5.4% 2024 Value Projection: 63 Billion (USD)
Pages: 185 Tables, Charts & Figures: 234
Geographies covered (17): U.S., Canada, Germany, France, UK, Italy, Spain, Russia, China, Japan, India, Australia, Brazil, Mexico, Saudi Arabia, South Africa, UAE
Segments covered: Service Type , End-user and Region
Companies covered (11): bioMerieux, Bio-Rad Laboratories, DexCom, Inc, Nova Biomedical, OraSure Technologies, Ortho Clinical Diagnostics, Qiagen, Roche Diagnostics, Siemens AG, Sysmex Corporation, Thermo Fisher Scientific
Growth Drivers:
  • Growing cases of cancer in Asia Pacific and North America
  • Increasing detection rate of genetic and infectious diseases in Europe and U.S.
  • Rising number of liquid biopsy tests
  • Technological advancements in point of care testing services in Europe
Pitfalls & Challenges:
  • High cost of diagnosis service

Get more details on this report - Request Free Sample PDF
 

In-vitro Diagnostic Services Market, By Service Type

Software segment will grow at 4.5% over the forecast timeframe due to growing preference for reliable and efficient diagnostic software that will help to maintain patient’s record. Also, software enables analysis of the gene sequencing information that will boost drug discovery process and is expected to render positive impact on segmental growth. In-vitro diagnostic companies such as Roche have partnered with Microsoft and Cleidon that will help in broadening its software offerings and will also prove beneficial for business growth.
 

Testing services segment was valued at USD 34.8 billion in 2017 and is projected to grow significantly over the forecast timeframe as a result of growing elderly population globally will augment demand for in-vitro diagnostic services surging the segmental growth. High demand for diagnostic services such as mammography, colonoscopy, blood tests and liquid biopsy should further augment the industry growth. According to CDC in 2015, 65.3% women in the age group of 40 years and above underwent the mammography tests in the U.S. that should impel segmental growth in forthcoming years.
 

In-vitro Diagnostic Services Market, By End-user

Hospital segment will grow at 4.3% over the forecast timeframe due to increasing prevalence of chronic diseases in developed as well as developing countries. Moreover, growing healthcare associated infections should impact the segmental growth positively. According to CDC in 2015, Americans spent around 32.3% of the total expenditures on hospital care that will enhance business growth.
 

Point-of-care testing segment accounted for 23.5% revenue share in 2017 and is expected to grow over the forecast timeframe. Technological advancements coupled with increasing prevalence of genetic diseases requiring critical monitoring should increase demand for point-of-care testing that will upsurge the segment growth in forthcoming years.
 

In-vitro Diagnostic Services Market, By Region

U.S. dominated North American market and was valued at USD 16.7 billion in 2017 as a result of increasing demand for diagnostic services and growing adoption rate of software. Development in public healthcare system will increase the availability of superior quality diagnostic services that should impel industry growth in upcoming years.
 

Germany market will grow at 4.5% CAGR over the estimated forecast timeframe. Exponential regional growth can be attributed to increasing adoption rate of superior quality diagnostic devices that enhances the performance of diagnostic procedures stimulating the industry growth in future. Moreover, increasing geriatric population preferring in-vitro diagnostic services will trigger the industry growth.
 

Competitive Market Share

Major industry players include bioMerieux SA, Bio-Rad Laboratories, DexCom, Nova Biomedical, OraSure Technologies, Ortho Clinical Diagnostics, Qiagen, Roche Diagnostics, Siemens AG, Sysmex Corporation and Thermo Fisher Scientific. These industry players adopt strategic initiatives that help them to maintain their market share. For instance, Roche developed Accu-Chek 360° diabetes management software that ensures accurate storage of patient’s information and helps in reviewing the historical data. Addition of new products to the portfolio will enhance revenue generation for the company.
 

In-vitro Diagnostic Services Industry Background  

IVD services market is consolidated in nature and is dominated by only few industry players. Additionally, in-vitro diagnostic services industry has evolved drastically and has led to improvements in the software developed by the companies. For instance, organizations such as Roche diagnostics and OraSure are merging with leading software companies to enhance their product offerings to sustain market competition. Also, with an increase in prevalence of cancer globally, the key industry players have added innovations in most preferred diagnostic tests such as mammography, echocardiography and colonoscopy that facilitates efficient diagnosis thereby, escalating demand for diagnostic services in forthcoming years. Furthermore, development in vendor and overall distribution network of the suppliers for software utilised under in-vitro diagnostic services will ensure sustainable industry growth.


Buy NowImmediate delivery available

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Premium Report Details

  • Published Date: Sep 2018
  • Pages: 185
  • Tables: 226
  • Charts / Figures: 8
  • Companies covered: 11
  • Countries covered: 17

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X